Skip to content

A 9010 · New York · 2025-2026 · Billy

Skip to content

Home
/
Bills
/
New York
/
2025-2026
/
A 9010

New York · 2025-2026 session · house

A 9010Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic

Status: In committee
Latest action: 2026-05-04 — AMEND AND RECOMMIT TO HEALTH
Primary sponsor: Linda Rosenthal (Democratic)

Track this bill View changes+24 / −19 words · Medium

Sponsors

Linda Rosenthal (Democratic) · primaryprimary
Emily Gallagher (Democratic) · cosponsor

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New York bill RSS

Phil Steck (Democratic) · cosponsor

MaryJane Shimsky (Democratic/Working Families) · cosponsor

Jo Anne Simon (Democratic) · cosponsor

Judy Griffin (Democratic) · cosponsor

Steve Stern (Democratic) · cosponsor

Versions

A9010—
A9010A—
A9010B—

Legislative history

May 4, 2026
AMEND AND RECOMMIT TO HEALTH
May 4, 2026
PRINT NUMBER 9010B
Jan 22, 2026
PRINT NUMBER 9010A
Jan 22, 2026
AMEND AND RECOMMIT TO HEALTH
Jan 7, 2026
REFERRED TO HEALTH
Aug 13, 2025
REFERRED TO HEALTH

Official sources

Version 0PDF HTML
Version 1PDF
Version 2PDF

About this page

Is this the official New York bill page?: No — this is Billy’s public legislative record for A 9010. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track A 9010, get alerts, annotate diffs, and export Word work product.